Stereotaxis (STXS) Other Non-Current Liabilities (2010 - 2026)
Stereotaxis' (STXS) quarterly Other Non-Current Liabilities came in at $5.1 million in Q1 2026, down 18.38% year-on-year from $6.3 million in Q1 2025, and up 8.13% on a QoQ basis from $4.7 million in Q4 2025.
Stereotaxis (STXS) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has 17 years of Other Non-Current Liabilities data on file, last reported at $5.1 million in Q1 2026.
- On a quarterly basis, Other Non-Current Liabilities fell 18.38% year-over-year to $5.1 million in Q1 2026; TTM through Mar 2026 was $5.1 million, a 18.38% decrease from a year earlier, with the FY2025 full-year figure at $4.7 million, down 22.89% from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $5.1 million, up from $4.7 million in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for STXS reached as high as $6.3 million in Q1 2025 and fell as low as $43000.0 in Q2 2023.
- Historically, Other Non-Current Liabilities has averaged $1.5 million across 5 years, with a median of $168000.0 in 2022.
- Across the five-year window, Other Non-Current Liabilities tumbled 78.71% in 2023 and soared 14453.49% in 2025, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $51000.0 in 2022, then slipped by 15.69% to $43000.0 in 2023, then surged by 14146.51% to $6.1 million in 2024, then fell by 22.89% to $4.7 million in 2025, then grew by 8.13% to $5.1 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $5.1 million in Q1 2026, $4.7 million in Q4 2025, and $1.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Stereotaxis | 136.49 Mn | 121.87 Mn | 3.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.11 Mn |
| Dec 31, 2025 | 4.72 Mn |
| Sep 30, 2025 | 1.10 Mn |
| Jun 30, 2025 | 1.11 Mn |
| Mar 31, 2025 | 6.26 Mn |
| Dec 31, 2024 | 6.13 Mn |
| Sep 30, 2024 | 55,000.00 |
| Jun 30, 2024 | 54,000.00 |
| Mar 31, 2024 | 43,000.00 |
| Dec 31, 2023 | 43,000.00 |
| Sep 30, 2023 | 43,000.00 |
| Jun 30, 2023 | 43,000.00 |
| Mar 31, 2023 | 51,000.00 |
| Dec 31, 2022 | 51,000.00 |
| Sep 30, 2022 | 168,000.00 |
| Jun 30, 2022 | 202,000.00 |
| Mar 31, 2022 | 202,000.00 |
| Dec 31, 2021 | 218,000.00 |
| Sep 30, 2021 | 215,861.00 |
| Jun 30, 2021 | 206,596.00 |